mutations and complex kar yotype. It follows a linear evolution with the CLL clone with the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions of the genome, are mainly situated in active promoters or enhancers, and modify the binding web-sites of several transcription elements.Deep,